Aspirin-Exacerbated Respiratory Disease (AERD) / Samter’s Triad: Why Your Polyps Keep Returning and How We Stop Them

Imagine dealing with severe asthma, losing your sense of smell entirely due to massive nasal polyps, and then experiencing a dangerous respiratory attack simply because you took an ibuprofen for a headache. This is the exhausting reality for patients suffering from Aspirin-Exacerbated Respiratory Disease (AERD), historically known as Samter’s Triad.

In my opinion, accurately diagnosing AERD is one of the most critical turning points in a patient's journey. Too often, these patients endure multiple sinus surgeries because their polyps grow back fast. They are frequently told they just have "severe allergies," but AERD is actually not a traditional allergy at all.

If we look deeply into the medical research, AERD is fundamentally a metabolic dysfunction in how your body processes certain enzymes—specifically within the arachidonic acid pathway. When you take Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like aspirin or ibuprofen, the drug blocks an enzyme called COX-1. In a normal person, this reduces pain. But in an AERD patient, blocking COX-1 acts like a dam, forcing inflammatory chemicals down a secondary pathway. This floods your system with leukotrienes—powerful inflammatory molecules that instantly trigger an asthma attack and drive explosive, rapid polyp growth. It is a highly aggressive form of systemic Type 2 Inflammation.

Because we are dealing with a deeply rooted metabolic flaw, standard allergy treatments and routine surgeries will always fail. To achieve lasting relief, we must deploy a targeted, three-pronged precision medicine strategy:

• Extended Endoscopic Sinus Surgery (ESS): We must first "reset" your anatomy. Because AERD polyps are notoriously aggressive, a standard surgery is not enough. We perform an extended, meticulous clearance of the polyp burden, opening the sinuses as widely as possible. This ensures that post-operative topical medications can actually reach the deepest corners of the sinus cavities to suppress micro-inflammation.

• Aspirin Desensitization Therapy: This is the traditional gold-standard medical protocol for AERD. Under strict clinical supervision, we gradually expose your body to increasing doses of aspirin until your system builds a tolerance. Once desensitized, taking a daily high-dose maintenance of aspirin paradoxically stops the leukotriene flood, drastically reducing asthma flare-ups and slowing polyp regrowth.

• Targeted Biologic Therapies: For patients who cannot tolerate aspirin desensitization or have highly recalcitrant disease, we now use Biologics. These are advanced monoclonal antibodies that specifically block the Type 2 inflammatory proteins (like IL-4 and IL-13) at the cellular level. Biologics act as precision missiles, effectively turning off the biological switch that causes polyps to grow, often restoring the sense of smell and preventing the need for future revision surgeries.

AERD is a formidable and relentless condition, but it is no longer an unbeatable one. By addressing the specific metabolic pathways driving the disease, rather than just endlessly cutting away polyps, we can break the cycle of recurrence and permanently restore your quality of life.

Wirach Chitsuthipakorn, MD
Rhinologist-Sinus surgeon. 

return to articles